• About
  • News
  • Team
  • Carriers

News

News List
[a:rti]Cure and nSAGE have signed an MOU to jointly develop the next-generation solid tumor treatment CAR-X using each company's platform technology.
Oct, 2024
[a:rti]Cure was selected for the non-clinical trial project of the National New Drug Development Program supported by the government.
May, 2024
[a:rti]Cure was selected for the drug candidate project of the National New Drug Development Program supported by the government.
May, 2022

Search

Articure
Representative : Yeon-Soo Kim Business Registration Number : 548-87-00954 Main Phone : +82-10-8367-7335 E-Mail : articure@icgm.kr
Address : Room 301, W1-1, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, South Korea.
Copyright © 2025 Articure. All rights reserved.
Designed By ADS&SOFT.
Scroll
유전자의약 이노베이션센터